Inotiv Inc. (NOTV)
2.92
0.17 (6.18%)
At close: Mar 24, 2025, 3:59 PM
2.93
0.34%
After-hours: Mar 24, 2025, 07:33 PM EDT
6.18% (1D)
| Bid | 2.1 |
| Market Cap | 98.9M |
| Revenue (ttm) | 592.48M |
| Net Income (ttm) | -150.5M |
| EPS (ttm) | -4.61 |
| PE Ratio (ttm) | -0.63 |
| Forward PE | -16.93 |
| Analyst | Buy |
| Ask | 3.66 |
| Volume | 138,727 |
| Avg. Volume (20D) | 663,513 |
| Open | 2.82 |
| Previous Close | 2.75 |
| Day's Range | 2.78 - 2.94 |
| 52-Week Range | 1.23 - 11.42 |
| Beta | 3.79 |
About NOTV
Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segment offers screening and pharmacological testing, nonclinical safety testing, formulation development, r...
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date Nov 25, 1997
Employees 1,977
Stock Exchange NASDAQ
Ticker Symbol NOTV
Website https://www.inotivco.com
Analyst Forecast
According to 3 analyst ratings, the average rating for NOTV stock is "Buy." The 12-month stock price forecast is $4, which is an increase of 36.99% from the latest price.
Stock ForecastsNext Earnings Release
Inotiv Inc. is scheduled to release its earnings on May 9, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
-28.83%
Inotic shares are trading lower after the company ...
Unlock content with
Pro Subscription
3 months ago
-4.48%
Inotic shares are trading lower after the company announced a public offering of common shares with a 15% over-allotment option.
